Major studies have proven that SGLT2 inhibitors significantly reduce the risk of hospitalization for heart failure and slow the progression of chronic kidney disease
CLA may cause an upset stomach, diarrhea, fatigue, and nausea
The same association may be observed in women (109)
7 Similar findings were also shown in another meta-analysis, demonstrating that GLP-1 receptor agonist treatment showed a significant 10% relative risk reduction in the three-point major adverse cardiovascular event primary outcome (cardiovascular mortality, non-fatal myocardial infarction, and non-fatal stroke), and a 12% relative risk reduction in all-cause mortality
The eye is a highly sensitive organ that can sometimes react unexpectedly to the strong metabolic interventions of this medication, and your vision can be damaged as a result
By integrating these findings, we provide novel insights into the molecular mechanisms underlying PC development and progression, which may facilitate the identification of new diagnostic biomarkers and therapeutic targets for this disease